Selkirk Pharma is a pharmaceutical product manufacturer with a mission to increase access to reliable medicine. The company works to provide aseptic drug injections in a safe and secure environment with logistic supply chain support, product inspections, microbiological testing, and endotoxin testing. Selkirk Pharma was founded by Patrick Haffey in 2018 and is headquartered in Spokane, WA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/06/2023 | Series Seed IV | $24.1MM | $xx.xx | $2.45B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
892,689
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
12/29/2021 | Series Seed III | $35MM | $xx.xx | $216.92MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,949,861
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
09/14/2020 | Series Seed II | $12.17MM | $xx.xx | $53.2MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,081,035
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
02/24/2020 | Series Seed I | $9.05MM | $xx.xx | $45.26MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,011,397
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|